11th Clinical Trials on Alzheimer’s Disease (CTAD)
The Clinical Trials on Alzheimer’s Disease (CTAD) conference is an important annual scientific meeting where latest developments and research results from clinical Alzheimer disease trials are shared and discussed. Researchers and participants from pharma, academia, patent-advocacy organizations and other groups are coming together in Barcelona, Spain, between October 24th and 27th.
Each year, on behalf of our consortium members, CPAD attends CTAD to share the latest milestones of our work with the research community, to educate ourselves on latest developments and trends, and to meet and exchange information with our members and other key opinion leaders. This year, one poster was accepted for presentation:
Kern et al.: “Critical Path for Alzheimer’s Disease (CPAD) consortium’s vision for an aggregated, standardized, and actionable global Alzheimer disease clinical trial database.”
Next year’s CTAD conference is scheduled for December 4-7, 2019 in San Diego, CA.